Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection

Journal of Virology

Volumn 88, Issue 8, 2014, Pages 4229-4236

  Liu, Tiantian ^a   Zang, Na ^a   Zhou, Na ^a   Li, Wei ^a   Xie, Xiaohong ^b   Deng, Yu ^b   Ren, Luo ^a   Long, Xiaoru ^a   Li, Simin ^b   Zhou, Lili ^a   Zhao, Xiaodong ^b   Tu, Wenwei ^c   Wang, Lijia ^a   Tan, Bin ^a   Liu, Enmei ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GAMMA INTERFERON; RESVERATROL; SMALL INTERFERING RNA; STERILE ALPHA AND ARMADILLO MOTIF PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY PLETHYSMOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; INNATE IMMUNITY; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ARMADILLO DOMAIN PROTEINS; CYTOSKELETAL PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; STILBENES; UP-REGULATION;

EID: 84896959806     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03637-13     Document Type: Article

References (49)

1. Hall C. 1994. Prospects for a respiratory syncytial virus vaccine. Science 265:1393-1394. http://dx.doi.org/10.1126/science.7915433.
2. Tregoning JS, Schwarze J. 2010. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 23:74-98. http://dx.doi.org/10.1128/CMR.00032-09.
3. Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, Cohen HJ. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315:77-81. http://dx.doi.org/10.1056/NEJM198607103150201.
4. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352:1749-1759. http://dx.doi.org/10.1056/NEJMoa043951.
5. Littel-van den Hurk SVD, Mapletoft JW, Arsic N, Kovacs-Nolan J. 2007. Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev. Med. Virol. 17:5-34. http://dx.doi.org/10.1002/rmv.518.
6. Athman R, Philpott D. 2004. Innate immunity via Toll-like receptors and Nod proteins. Curr. Opin. Microbiol. 7:25-32. http://dx.doi.org/10.1016/j.mib.2003.12.013.
7. Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich H-J, van Rooijen N, Gatalica Z, Garofalo RP. 2002. Respiratory syncytial virusinduced activation of nuclear factor-κB in the lung involves alveolar mac-rophages and Toll-like receptor 4-dependent pathways. J. Infect. Dis. 186: 1199-1206. http://dx.doi.org/10.1086/344644.
8. Ubol S, Halstead SB. 2010. How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin. Vaccine Immunol. 17:1829-1835. http://dx.doi.org/10.1128/CVI.00316-10.
9. O'Neill LAJ, Fitzgerald KA, Bowie AG. 2003. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24:286-289. http://dx.doi.org/10.1016/S1471-4906(03)00115-7.
10. Couillault C, Pujol N, Reboul J, Sabatier L, Guichou J-F, Kohara Y, Ewbank JJ. 2004. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 5:488-494. http://dx.doi.org/10.1038/ni1060.
11. O'Neill LAJ, Bowie AG. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353-364. http://dx.doi.org/10.1038/nri2079.
12. Belinda LW-C, Wei WX, Hanh BTH, Lei LX, Bow H, Ling DJ. 2008. SARM: a novel Toll-like receptor adaptor, is functionally conserved from arthropod to human. Mol. Immunol. 45:1732-1742. http://dx.doi.org/10.1016/j.molimm.2007.09.030.
13. Carty M, Goodbody R, Schröder M, Stack J, Moynagh PN, Bowie AG. 2006. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7:1074-1081. http://dx.doi.org/10.1038/ni1382.
14. Peng J, Yuan Q, Lin B, Panneerselvam P, Wang X, Luan XL, Lim SK, Leung BP, Ho B, Ding JL. 2010. SARM inhibits both TRIF-and MyD88-mediated AP-1 activation. Eur. J. Immunol. 40:1738-1747. http://dx.doi.org/10.1002/eji.200940034.
15. Yu XM, Luo L. 2012. Neuroscience. dSarm-ing axon degeneration. Science 337:418-419. http://dx.doi.org/10.1126/science.1226150.
16. Chen CY, Lin CW, Chang CY, Jiang ST, Hsueh YP. 2011. Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology. J. Cell Biol. 193:769-784. http://dx.doi.org/10.1083/jcb.201008050.
17. Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, Sheehan AE, Avery MA, Hackett R, Logan MA, MacDonald JM, Ziegenfuss JS, Milde S, Hou YJ, Nathan C, Ding A, Brown RH, Conforti L, Coleman M, Tessier-Lavigne M, Zuchner S, Freeman MR. 2012. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337:481-484. http://dx.doi.org/10.1126/science.1223899.
18. Panneerselvam P, Singh Laishram P, Ho B, Chen J, Ding Jeak L. 2012. Targeting of pro-apoptotic TLR adaptor SARM to mitochondria: definition of the critical region and residues in the signal sequence. Biochem. J. 442:263-271. http://dx.doi.org/10.1042/BJ20111653.
19. Panneerselvam P, Singh LP, Selvarajan V, Chng WJ, Ng SB, Tan NS, Ho B, Chen J, Ding JL. 2013. T-cell death following immune activation is mediated by mitochondria-localized SARM. Cell Death Differ. 20:478-489. http://dx.doi.org/10.1038/cdd.2012.144.
20. Bråkenhielm E, Cao R, Cao Y. 2001. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 15:1798-1800. http://dx.doi.org/10.1096/fj.01-0028fje.
21. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH. 2005. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175:3339-3346.
22. Kim MH, Yoo DS, Lee SY, Byeon SE, Lee YG, Min T, Rho HS, Rhee MH, Lee J, Cho JY. 2011. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broadspectrum anti-inflammatory effects. Pharmazie 66:293-300. http://dx.doi.org/10.1691/ph.2011.0798.
23. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220. http://dx.doi.org/10.1126/science.275.5297.218.
24. Bradamante S, Barenghi L, Villa A. 2004. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 22:169-188. http://dx.doi.org/10.1111/j.1527-3466.2004.tb00139.x.
25. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. 2002. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958:439-447. http://dx.doi.org/10.1016/S0006-8993(02)03543-6.
26. Xie X-H, Law HKW, Wang L-J, Li X, Yang X-Q, Liu E-M. 2009. Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the Toll-like receptor 4 signaling pathway. Pediatr. Res. 65:156-162. http://dx.doi.org/10.1203/PDR.0b013e318191f5c6.
27. Zang N, Xie X, Deng Y, Wu S, Wang L, Peng C, Li S, Ni K, Luo Y, Liu E. 2011. Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice. J. Virol. 85:13061-13068. http://dx.doi.org/10.1128/JVI.05869-11.
28. Royce SG, Dang W, Yuan G, Tran J, El Osta A, Karagiannis TC, Tang MLK. 2011. Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease. Pathobiol. Aging Age Relat. Dis. 2011:1. http://dx.doi.org/10.3402/PBA.v1i0.7134.
29. Chung EY, Kim BH, Hong J-T, Lee C-K, Ahn B, Nam S-Y, Han S-B, Kim Y. 2011. Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. J. Nutr. Biochem. 22:902-909. http://dx.doi.org/10.1016/j.jnutbio.2010.07.012.
30. Kobayashi M, Ashino S, Shiohama Y, Wakita D, Kitamura H, Nishimura T. 2012. IFN-γ elevates airway hyper-responsiveness via upregulation of neurokinin A/neurokinin-2 receptor signaling in a severe asthma model. Eur. J. Immunol. 42:393-402. http://dx.doi.org/10.1002/eji.201141845.
31. Jafri HS, Chávez-Bueno S, Mejías A, Gómez AM, Ríos AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O. 2004. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J. Infect. Dis. 189:1856-1865. http://dx.doi.org/10.1086/386372.
32. McKimm-Breschkin JL. 2004. A simplified plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. J. Virol. Methods 120:113-117. http://dx.doi.org/10.1016/j.jviromet.2004.02.020.
33. Graham BS, Bunton LA, Wright PF, Karzon DT. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Investig. 88:1026-1033. http://dx.doi.org/10.1172/JCI115362.
34. Myou S, LeffAR, Myo S, Boetticher E, Tong J, Meliton AY, Liu J, Munoz NM, Zhu X. 2003. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J. Exp. Med. 198:1573-1582. http://dx.doi.org/10.1084/jem.20030298.
35. Ogawa H, Azuma M, Uehara H, Takahashi T, Nishioka Y, Sone S, Izumi K. 2012. Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA. Clin. Exp. Allergy 42:460-470. http://dx.doi.org/10.1111/j.1365-2222.2011.03918.x.
36. van Woensel JB, Lutter R, Biezeveld M, Dekker T, Nijhuis M, Van Aalderen WM, Kuijpers TW. 2003. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 22:721-726. http://dx.doi.org/10.1097/01.inf.0000078165.62923.15.
37. Kong X, Hellermann GR, Patton G, Kumar M, Behera A, Randall TS, Zhang J, Lockey RF, Mohapatra SS. 2005. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virol. J. 2:3. http://dx.doi.org/10.1186/1743-422X-2-3.
38. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401. http://dx.doi.org/10.1038/80833.
39. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732-738. http://dx.doi.org/10.1038/35099560.
40. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737. http://dx.doi.org/10.1038/ni1087.
41. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
42. Xie X-H, Zang N, Li S-M, Wang L-J, Deng Y, He Y, Yang X-Q, Liu E-M. 2012. Resveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells. Inflammation 35:1392-1401. http://dx.doi.org/10.1007/s10753-012-9452-7.
43. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. 2001. Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:10730-10737. http://dx.doi.org/10.1128/JVI.75.22.10730-10737.2001.
44. Douville RN, Bastien N, Li Y, Simons FER, HayGlass KT. 2007. Adult asthmatics display exaggerated IFNγ responses to human metapneumovirus and respiratory syncytial virus. Biochem. Cell Biol. 85:252-258. http://dx.doi.org/10.1139/O07-005.
45. Fioravanti R, Celestino I, Costi R, Cuzzucoli Crucitti G, Pescatori L, Mattiello L, Novellino E, Checconi P, Palamara AT, Nencioni L, Santo RD. 2012. Effects of polyphenol compounds on influenza A virus replication and definition of their mechanism of action. Bioorg. Med. Chem. 20:5046-5052. http://dx.doi.org/10.1016/j.bmc.2012.05.062.
46. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond MS. 2009. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile virus pathogenesis. J. Virol. 83:9329-9338. http://dx.doi.org/10.1128/JVI.00836-09.
47. Netea MG, Van der Meer JWM, Sutmuller RP, Adema GJ, Kullberg B-J. 2005. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob. Agents Chemother. 49:3991-3996. http://dx.doi.org/10.1128/AAC.49.10.3991-3996.2005.
48. Becker Y. 2006. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy: a review. Virus Genes 33:235-252. http://dx.doi.org/10.1007/s11262-006-0064-x.
49. Negishi H, Osawa T, Ogami K, Ouyang X, Sakaguchi S, Koshiba R, Yanai H, Seko Y, Shitara H, Bishop K, Yonekawa H, Tamura T, Kaisho T, Taya C, Taniguchi T, Honda K. 2008. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. U. S. A. 105:20446-20451. http://dx.doi.org/10.1073/pnas.0810372105.